3 results
Approved WMOPending
Phase 1:The primary objective of this trial is to investigate whether oral esketamine is non-inferior to ECT after eight weeks of individually optimized treatment, in participants with NTRD.Phase 2:To compare the efficacy of maintenance oral…
Approved WMOCompleted
Primary objective The primary objective of the study is the evaluation of the therapeutic benefit of three repeated dose intratympanic AM 101 injections in comparison to placebo in the treatment of persistent acute inner ear tinnitus following acute…
Approved WMORecruiting
To investigate whether oral esketamine is non-inferior to ECT in achieving treatment response on depression severity in NTRD.